My Portfolio
My Watchlists
Profile & Performance
Smart Portfolio
Find & Follow Experts
Top Lists
Top Experts
Make Better, Data Driven Investment Decisions
TipRanks tools are all you need to make data-driven investment decisions, conduct comprehensive stock research, find new investment ideas, analyze your portfolio, and follow the best-performing Wall Street experts.
About Us
Plans & Pricing
Coherus Biosciences (CHRS)
NASDAQ:CHRS

Coherus Biosciences Stock Investors

Based on 519,446 investor portfolios analyzed by TipRanks Open your own Smart Portfolio >

Average Holdings Size

<0.1% of all portfolios hold CHRS
On average, investors allocate 2.98% of their portfolios to CHRS
The average holding size of this company in investors' portfolios.

Investor Sentiment

Very Positive
Sector
Average
Stock Sentiment
Sold
Bought
Based on the activity of 519,446 investors in the recent quarter
The overall sentiment of all investors covering this stock. Click on ‘Top Investors’ to focus on the best performers.

Portfolios Holding CHRS

3.8%
Last 7
Days
1.9%
Last 30
Days
Percentages indicate the change in the number of portfolios holding CHRS, out of 519,446 portfolios.
The average increase or decrease in average holding size of this stock in investor portfolios in the last 7 days or last 30 days.

CHRS Investor Activity

Investor Profile
Investor Action
Transaction Date
Portfolio Allocation
Execution Price
Follow
Closed
0.00%
$17.52
Closed
0.00%
$17.39
Closed
0.00%
$17.09
Closed
0.00%
$17.24
Closed
0.00%
$15.70
Closed
0.00%
$15.75
Based on the activity of 43,800 investors who made their portfolios public
The table shows changes in CHRS in the past 3 months by investors with public portfolios.
Investor activity updates every 24 hours.

CHRS Investors Also Bought

Name
Average Holding Size
Last 7D Change
Last 30D Change
Market Cap
Sector
3M Behavior
Follow
PLUGPlug Power
9.47%
0.05%
-0.54%
$24.73B
Technology
VKTXViking Therapeutics
5.12%
1.23%
-4.84%
$441.24M
Healthcare
GTHXG1 Therapeutics
8.13%
0.79%
-1.52%
$566.40M
Healthcare
RIGLRigel
1.96%
4.09%
3.42%
$521.57M
Healthcare
AUPHAurinia Pharmaceuticals
13.68%
7.12%
9.28%
$3.69B
Healthcare
MUMicron
6.86%
-0.58%
-8.44%
$93.81B
Technology
GILDGilead Sciences
3.56%
-1.28%
-5.17%
$87.89B
Healthcare
NVAXNovavax
14.17%
0.24%
2.87%
$15.18B
Healthcare
GBTGlobal Blood Therapeutics
4.20%
4.14%
-2.89%
$2.02B
Healthcare
LCTXLineage Cell Therapeutics
6.94%
0.58%
-0.29%
$386.00M
Healthcare
Based on the activity of 519,446 active portfolios
Open your Smart Portfolio

CHRS Investor Analysis

CHRS investors under 35

Under 35

18.8%
Last 30 days
Holdings Change
21.3%
of CHRS holders
are under 35
Average Segment Performance
Monthly Return1.51%
Beta1.42
Dividend Yield7.08%
CHRS investors between 35–55

Between 35–55

6.1%
Last 30 days
Holdings Change
46.8%
of CHRS holders
are between 35–55
Average Segment Performance
Monthly Return1.61%
Beta5.17
Dividend Yield26.84%
CHRS investors over 55

Over 55

9.8%
Last 30 days
Holdings Change
31.9%
of CHRS holders
are over 55
Average Segment Performance
Monthly Return1.62%
Beta1.26
Dividend Yield7.23%
Overview of age group and performance of CHRS stock investors
See who invests in CHRS according to age group and performance.

Stocks with the Most Positive Individual Investor Sentiment in the Healthcare sector
FTRPField Trip Health
MCURFMind Cure Health
ENTBFEntheon Biomedical
SEHCFSweet Earth Holdings
CGEMCullinan Management

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis